A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov

• Published in: Discover. Oncology Vol. 14; no. 1; p. 151
• Main Authors: Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia
• Format: Journal Article
• Language: English
• Published: New York Springer US 21.08.2023; Springer Nature B.V; Springer
• Subjects: Adenosine; Apoptosis; Bispecific antibodies; Cancer Research; Cancer therapies; Chemokines; Clinical trials; Combination therapy; Cyclin-dependent kinases; Data processing; Drugs; Endocrine therapy; FDA approval; Growth factors; Immuno-oncology therapy; Internal Medicine; Kinase inhibitors; Kinases; Medicine; Medicine & Public Health; Molecular Medicine; Oncology; PD-1/PD-L1 inhibitors; Pharmaceutical industry; Radiotherapy; Steroids; Surgical Oncology; Targeted therapy; Tumors; Immuno-oncology therapy; PD-1/PD-L1 inhibitors; Combination therapy; Kinase inhibitors; Targeted therapy; Bispecific antibodies

Combination therapies have taken center stage for cancer treatment, however, there is a lack of a comprehensive portrait to quantitatively map the current clinical combination progress. This study aims to capture clinical combination therapies of the validated FDA-approved new oncology drugs by a ma...